Works matching IS 08876924 AND DT 2010 AND VI 24 AND IP 5

Results: 36

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up.

Published in:

2010

By:

Shimoni, A.;
Hardan, I.;
Shem-Tov, N.;
Yerushalmi, R.;
Nagler, A.

Publication type:

Letter

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1.

Published in:

2010

By:

Jenal, M.;
Batliner, J.;
Reddy, V. A.;
Haferlach, T.;
Tobler, A.;
Fey, M. F.;
Torbett, B. E.;
Tschan, M. P.

Publication type:

Letter

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.

Published in:

2010

By:

Medves, S.;
Duhoux, F. P.;
Ferrant, A.;
Toffalini, F.;
Ameye, G.;
Libouton, J.-M.;
Poirel, H. A.;
Demoulin, J.-B.

Publication type:

Letter

Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1012, doi. 10.1038/leu.2010.30

By:

Chen, J.;
Li, Y.;
Doedens, M.;
Wang, P.;
Shago, M.;
Dick, J.;
Hitzler, J. K.

Publication type:

Article

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Published in:

2010

By:

Boultwood, J.;
Perry, J.;
Pellagatti, A.;
Fernandez-Mercado, M.;
Fernandez-Santamaria, C.;
Calasanz, M. J.;
Larrayoz, M. J.;
Garcia-Delgado, M.;
Giagounidis, A.;
Malcovati, L.;
Della Porta, M. G.;
Jädersten, M.;
Killick, S.;
Hellström-Lindberg, E.;
Cazzola, M.;
Wainscoat, J. S.

Publication type:

Letter

AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1065, doi. 10.1038/leu.2010.22

By:

Haferlach, C.;
Dicker, F.;
Kohlmann, A.;
Schindela, S.;
Weiss, T.;
Kern, W.;
Schnittger, S.;
Haferlach, T.

Publication type:

Article

JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5.

Published in:

2010

By:

Cleyrat, C.;
Jelinek, J.;
Girodon, F.;
Boissinot, M.;
Ponge, T.;
Harousseau, J.-L.;
Issa, J.-P.;
Hermouet, S.

Publication type:

Letter

Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma.

Published in:

2010

By:

Abdou, A. M.;
Gao, X.;
Cozen, W.;
Cerhan, J. R.;
Rothman, N.;
Martin, M. P.;
Davis, S.;
Schenk, M.;
Chanock, S. J.;
Hartge, P.;
Carrington, M.;
Wang, S. S.

Publication type:

research

Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.

Published in:

2010

By:

Hurton, L. V.;
Siddik, R. I.;
Singh, H.;
Olivares, S.;
Rabinovich, B. A.;
Tian, R.;
Mojsilovic, D.;
Hildebrand, W.;
Lee, D. A.;
Kelly, S. S.;
Champlin, R.;
Shpall, E. J.;
Fernandez-Viña, M.;
Cooper, L. J. N.;
Fernandez-Viña, M

Publication type:

Letter

Wilms’ tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 992, doi. 10.1038/leu.2010.33

By:

Vidovic, K.;
Svensson, E.;
Nilsson, B.;
Thuresson, B.;
Olofsson, T.;
Lennartsson, A.;
Gullberg, U.

Publication type:

Article

Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN.

Published in:

2010

By:

Yu, H.;
Li, Y.;
Gao, C.;
Fabien, L.;
Jia, Y.;
Lu, J.;
Silberstein, L. E.;
Pinkus, G. S.;
Ye, K.;
Chai, L.;
Luo, H. R.

Publication type:

Letter

Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1025, doi. 10.1038/leu.2010.35

By:

Singh, R. R.;
Kim, J. E.;
Davuluri, Y.;
Drakos, E.;
Cho-Vega, J. H.;
Amin, H. M.;
Vega, F.

Publication type:

Article

CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 958, doi. 10.1038/leu.2010.36

By:

Vaisitti, T.;
Aydin, S.;
Rossi, D.;
Cottino, F.;
Bergui, L.;
D'Arena, G.;
Bonello, L.;
Horenstein, A. L.;
Brennan, P.;
Pepper, C.;
Gaidano, G.;
Malavasi, F.;
Deaglio, S.

Publication type:

Article

Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.

Published in:

2010

By:

Pulikkan, J. A.;
Dengler, V.;
Peer Zada, A. A.;
Kawasaki, A.;
Geletu, M.;
Pasalic, Z.;
Bohlander, S. K.;
Ryo, A.;
Tenen, D. G.;
Behre, G.

Publication type:

journal article

Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.

Published in:

2010

By:

Landmeier, S.;
Altvater, B.;
Pscherer, S.;
Meltzer, J.;
Sebire, N.;
Pule, M.;
Vera, J.;
Hotfilder, M.;
Juergens, H.;
Vormoor, J.;
Rossig, C.

Publication type:

Letter

Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 924, doi. 10.1038/leu.2010.39

By:

Davidsson, J.;
Paulsson, K.;
Lindgren, D.;
Lilljebjörn, H.;
Chaplin, T.;
Forestier, E.;
Andersen, M. K.;
Nordgren, A.;
Rosenquist, R.;
Fioretos, T.;
Young, B. D.;
Johansson, B.

Publication type:

Article

AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1018, doi. 10.1038/leu.2010.40

By:

Komeno, Y;
Kitaura, J;
Watanabe-Okochi, N;
Kato, N;
Oki, T;
Nakahara, F;
Harada, Y;
Harada, H;
Shinkura, R;
Nagaoka, H;
Hayashi, Y;
Honjo, T;
Kitamura, T

Publication type:

Article

Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 932, doi. 10.1038/leu.2010.41

By:

Deneberg, S.;
Grövdal, M.;
Karimi, M.;
Jansson, M.;
Nahi, H.;
Corbacioglu, A.;
Gaidzik, V.;
Döhner, K.;
Paul, C.;
Ekström, T. J.;
Hellström-Lindberg, E.;
Lehmann, S.

Publication type:

Article

Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

Published in:

2010

By:

Yassin, E. R.;
Abdul-Nabi, A. M.;
Takeda, A.;
Yaseen, N. R.

Publication type:

journal article

A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.

Published in:

2010

By:

Ji, Z.;
Zhang, L.;
Peng, V.;
Ren, X.;
McHale, C. M.;
Smith, M. T.

Publication type:

journal article

Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma.

Published in:

2010

By:

Hockley, S. L.;
Morilla, A.;
Else, M.;
Dearden, C.;
Catovsky, D.;
Morgan, G. J.;
Matutes, E.;
Gonzalez, D.

Publication type:

Letter

Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP.

Published in:

2010

By:

Koehrer, S.;
Keating, M. J.;
Wierda, W. G.

Publication type:

Case Study

CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.

Published in:

2010

By:

Efanov, A.;
Zanesi, N.;
Nazaryan, N.;
Santanam, U.;
Palamarchuk, A.;
Croce, C. M.;
Pekarsky, Y.

Publication type:

journal article

EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 942, doi. 10.1038/leu.2010.47

By:

Balgobind, B. V.;
Lugthart, S.;
Hollink, I. H.;
Arentsen-Peters, S. T. J. C. M.;
van Wering, E. R.;
de Graaf, S. S. N.;
Reinhardt, D.;
Creutzig, U.;
Kaspers, G. J. L.;
de Bont, E. S. J. M.;
Stary, J.;
Trka, J.;
Zimmermann, M.;
Beverloo, H. B.;
Pieters, R.;
Delwel, R.;
Zwaan, C. M.;
van den Heuvel-Eibrink, M. M.

Publication type:

Article

MSK1 activation in acute myeloid leukemia cells with FLT3 mutations.

Published in:

2010

By:

Odgerel, T.;
Kikuchi, J.;
Wada, T.;
Shimizu, R.;
Kano, Y.;
Furukawa, Y.

Publication type:

Letter

CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.

Published in:

2010

By:

Shiba, N.;
Kato, M.;
Park, M.-j.;
Sanada, M.;
Ito, E.;
Fukushima, K.;
Sako, M.;
Arakawa, H.;
Ogawa, S.;
Hayashi, Y.

Publication type:

Letter

Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates.

Published in:

2010

By:

Caramazza, D.;
Ketterling, R. P.;
Knudson, R. A.;
Hanson, C. A.;
Siragusa, S.;
Pardanani, A.;
Tefferi, A.

Publication type:

Letter

POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.

Published in:

2010

By:

Fortier, J. M.;
Payton, J. E.;
Cahan, P.;
Ley, T. J.;
Walter, M. J.;
Graubert, T. A.

Publication type:

journal article

Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex.

Published in:

2010

By:

Ratajczak, M. Z.;
Lee, H.;
Wysoczynski, M.;
Wan, W.;
Marlicz, W.;
Laughlin, M. J.;
Kucia, M.;
Janowska-Wieczorek, A.;
Ratajczak, J.

Publication type:

journal article

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells.

Published in:

2010

By:

Puissant,3, A.;
Dufies, M.;
Raynaud, S.;
Cassuto, J.-P.;
Auberger, P.

Publication type:

Letter

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.

Published in:

2010

By:

Ho, P. A.;
Alonzo, T. A.;
Kopecky, K. J.;
Miller, K. L.;
Kuhn, J.;
Zeng, R.;
Gerbing, R. B.;
Raimondi, S. C.;
Hirsch, B. A.;
Oehler, V.;
Hurwitz, C. A.;
Franklin, J. L.;
Gamis, A. S.;
Petersdorf, S. H.;
Anderson, J. E.;
Reaman, G. H.;
Baker, L. H.;
Willman, C. L.;
Bernstein, I. D.;
Radich, J. P.

Publication type:

journal article

Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1037, doi. 10.1038/leu.2010.58

By:

Palumbo, A.;
Larocca, A.;
Falco, P.;
Sanpaolo, G.;
Falcone, A. P.;
Federico, V.;
Canepa, L.;
Crugnola, M.;
Genuardi, M.;
Magarotto, V.;
Petrucci, M. T;
Boccadoro, M.

Publication type:

Article

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Published in:

2010

By:

Kosmider, O.;
Gelsi-Boyer, V.;
Slama, L.;
Dreyfus, F.;
Beyne-Rauzy, O.;
Quesnel, B.;
Hunault-Berger, M.;
Slama, B.;
Vey, N.;
Lacombe, C.;
Solary, E.;
Birnbaum, D.;
Bernard, O. A.;
Fontenay, M.

Publication type:

Letter

Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.

Published in:

Leukemia (08876924), 2010, v. 24, n. 5, p. 1043, doi. 10.1038/leu.2010.62

By:

Terpos, E.;
Berenson, J.;
Cook, R. J.;
Lipton, A.;
Coleman, R. E.

Publication type:

Article

Retraction. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between the NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.

Published in:

2010

By:

Cilloni, D;
Messa, F;
Rosso, V;
Arruga, F;
Defilippi, I;
Carturan, S;
Catalano, R;
Pautasso, M;
Panuzzo, C;
Nicoli, P;
Messa, E;
Morotti, A;
Iacobucci, I;
Martinelli, G;
Bracco, E;
Saglio, G

Publication type:

corrected article

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

Published in:

2010

By:

Hochhaus, A;
O'Brien, S G;
Guilhot, F;
Druker, B J;
Branford, S;
Foroni, L;
Goldman, J M;
Müller, M C;
Radich, J P;
Rudoltz, M;
Mone, M;
Gathmann, I;
Hughes, T P;
Larson, R A

Publication type:

Correction Notice